Bloomberg News

Acrux Says Europe Marketing Authorization for Recuvyra Granted

October 12, 2011

Oct. 13 (Bloomberg) -- Acrux Ltd. said the European Medicines Agency has granted the marketing authorization for commercial use of Recuvyra 50 mg/mL transdermal solution for dogs, according to a regulatory filing.

Link to Statement:{NSN LSZ7B53PR6RL <GO>}

To contact the editor responsible for this story: Victoria Batchelor at vbatchelor@bloomberg.net


Steve Ballmer, Power Forward
LIMITED-TIME OFFER SUBSCRIBE NOW
 
blog comments powered by Disqus